.
Press 2019
|
Dec 03, 2019 |
|
Biostage Receives Response from the FDA for Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal Implant
|
|
Nov 12, 2019 |
|
Biostage Reports Third Quarter 2019 Financial Results
|
|
Nov 06, 2019 |
|
Biostage to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Business Update
|
|
Oct 30, 2019 |
|
Biostage Submits Investigational New Drug (IND) Application for Lead Product Candidate Cellspan™ Esophageal Implant for Treatment of Esophageal Conditions
|
|
Aug 13, 2019 |
|
Biostage Reports Second Quarter 2019 Financial Results
|
|
Aug 07, 2019 |
|
Biostage to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Business Update
|
|
May 14, 2019 |
|
Biostage Reports First Quarter 2019 Financial Results
|
|
May 08, 2019 |
|
Biostage to Host Conference Call to Discuss First Quarter 2019 Financial Results and Business Update
|
|
Mar 28, 2019 |
|
Biostage Reports 2018 Financial Results
|
|
Mar 21, 2019 |
|
Biostage to Host Conference Call to Discuss 2018 Financial Results and Business Update
|
|
Jan 28, 2019 |
|
First-In-Human Case Using Biostage's Bioengineered Esophageal Implant is Presented at Major Surgical Meeting
|